BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shin EJ, Canto MI. Pancreatic cancer screening. Gastroenterol Clin North Am. 2012;41:143-157. [PMID: 22341255 DOI: 10.1016/j.gtc.2011.12.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Lennon AM, Victor D, Zaheer A, Ostovaneh MR, Jeh J, Law JK, Rezaee N, Molin MD, Ahn YJ, Wu W. Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms. Liver Transpl. 2014;20:1462-1467. [PMID: 25155689 DOI: 10.1002/lt.23983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
2 Marley AR, Fan H, Hoyt ML, Anderson KE, Zhang J. Intake of methyl-related nutrients and risk of pancreatic cancer in a population-based case-control study in Minnesota. Eur J Clin Nutr 2018;72:1128-35. [PMID: 29904184 DOI: 10.1038/s41430-018-0228-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Roch AM, Schneider J, Carr RA, Lancaster WP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM, Ceppa EP. Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? J Surg Oncol. 2019;119:777-783. [PMID: 30636051 DOI: 10.1002/jso.25376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kumar SA, Thakur C, Li L, Cui H, Chen F. Pathological and prognostic role of mdig in pancreatic cancer. Genes Cancer 2017;8:650-8. [PMID: 28966726 DOI: 10.18632/genesandcancer.149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Eissa MAL, Lerner L, Abdelfatah E, Shankar N, Canner JK, Hasan NM, Yaghoobi V, Huang B, Kerner Z, Takaesu F, Wolfgang C, Kwak R, Ruiz M, Tam M, Pisanic TR 2nd, Iacobuzio-Donahue CA, Hruban RH, He J, Wang TH, Wood LD, Sharma A, Ahuja N. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood. Clin Epigenetics. 2019;11:59. [PMID: 30953539 DOI: 10.1186/s13148-019-0650-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
6 Škrha J, Bušek P, Uhrová J, Hrabal P, Kmochová K, Laclav M, Bunganič B, Frič P. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss. Pancreatology 2017;17:89-94. [PMID: 28027898 DOI: 10.1016/j.pan.2016.12.004] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
7 Chen J, Domingue JC, Sears CL. Microbiota dysbiosis in select human cancers: Evidence of association and causality. Semin Immunol 2017;32:25-34. [PMID: 28822617 DOI: 10.1016/j.smim.2017.08.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 18.5] [Reference Citation Analysis]
8 Rahman F, Cotterchio M, Cleary SP, Gallinger S. Association between alcohol consumption and pancreatic cancer risk: a case-control study. PLoS One. 2015;10:e0124489. [PMID: 25856529 DOI: 10.1371/journal.pone.0124489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
9 Zhang D, Xu XL, Li F, Sun HC, Cui YQ, Liu S, Xu PY. Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers. Oncol Lett 2017;14:8042-50. [PMID: 29344247 DOI: 10.3892/ol.2017.7239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 ASGE Standards of Practice Committee, Eloubeidi MA, Decker GA, Chandrasekhara V, Chathadi KV, Early DS, Evans JA, Fanelli RD, Fisher DA, Foley K, Hwang JH, Jue TL, Lightdale JR, Pasha SF, Saltzman JR, Sharaf R, Shergill AK, Cash BD, DeWitt JM. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest Endosc. 2016;83:17-28. [PMID: 26706297 DOI: 10.1016/j.gie.2015.09.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
11 Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol 2016; 22(44): 9694-9705 [PMID: 27956793 DOI: 10.3748/wjg.v22.i44.9694] [Cited by in CrossRef: 517] [Cited by in F6Publishing: 449] [Article Influence: 103.4] [Reference Citation Analysis]
12 Yachida S, Iacobuzio-Donahue CA. Evolution and dynamics of pancreatic cancer progression. Oncogene 2013;32:5253-60. [PMID: 23416985 DOI: 10.1038/onc.2013.29] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 15.0] [Reference Citation Analysis]
13 Gupta N, Yelamanchi R. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World J Gastroenterol 2021; 27(23): 3158-3181 [PMID: 34163104 DOI: 10.3748/wjg.v27.i23.3158] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Moutinho-ribeiro P, Coelho R, Giovannini M, Macedo G. Pancreatic cancer screening: Still a delusion? Pancreatology 2017;17:754-65. [DOI: 10.1016/j.pan.2017.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10:10-27. [PMID: 30834048 DOI: 10.14740/wjon1166] [Cited by in Crossref: 473] [Cited by in F6Publishing: 444] [Article Influence: 236.5] [Reference Citation Analysis]
16 Wadhwa V, Patwardhan S, Garg SK, Lopez R, Sanaka MR. Inpatient Burden of Pancreatic Cancer in the United States: An Analysis of National Trends in the United States From 1997 to 2012. Pancreas 2016;45:e41-2. [PMID: 27518364 DOI: 10.1097/MPA.0000000000000648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Park MY, Lee W, Kwon J, Song KB, Hwang DW, Lee JH, Kim SC. Comparison of perioperative outcomes in pancreatic head cancer patients following either a laparoscopic or open pancreaticoduodenectomy with a superior mesenteric artery first approach. Ann Hepatobiliary Pancreat Surg 2021;25:358-65. [PMID: 34402436 DOI: 10.14701/ahbps.2021.25.3.358] [Reference Citation Analysis]
18 Pandharipande PV, Heberle C, Dowling EC, Kong CY, Tramontano A, Perzan KE, Brugge W, Hur C. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Radiology 2015;275:177-87. [PMID: 25393849 DOI: 10.1148/radiol.14141282] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
19 Ma J, Jemal A. The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend? Future Oncol. 2013;9:917-919. [PMID: 23837751 DOI: 10.2217/fon.13.76] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
20 Lee HS, Jang CY, Kim SA, Park SB, Jung DE, Kim BO, Kim HY, Chung MJ, Park JY, Bang S, Park SW, Song SY. Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer. Sci Rep 2018;8:3383. [PMID: 29467409 DOI: 10.1038/s41598-018-21823-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
21 Koo D, Han K, Kim HJ, Park C. Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study. Acta Diabetol 2020;57:197-202. [DOI: 10.1007/s00592-019-01405-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Dalal V, Carmicheal J, Dhaliwal A, Jain M, Kaur S, Batra SK. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action. Cancer Lett 2020;469:228-37. [PMID: 31629933 DOI: 10.1016/j.canlet.2019.10.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
23 Gheorghe G, Bungau S, Ilie M, Behl T, Vesa CM, Brisc C, Bacalbasa N, Turi V, Costache RS, Diaconu CC. Early Diagnosis of Pancreatic Cancer: The Key for Survival. Diagnostics (Basel) 2020;10:E869. [PMID: 33114412 DOI: 10.3390/diagnostics10110869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
24 Christodoulou E, Visser M, Potjer TP, van der Stoep N, Rodríguez-Girondo M, van Doorn R, Gruis N. Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers. Fam Cancer 2019;18:439-44. [PMID: 31203567 DOI: 10.1007/s10689-019-00137-5] [Reference Citation Analysis]
25 Tan XP, Dong WG, Zhang Q, Yang ZR, Lei XF, Ai MH. Potential effects of Mina53 on tumor growth in human pancreatic cancer. Cell Biochem Biophys 2014;69:619-25. [PMID: 24522517 DOI: 10.1007/s12013-014-9841-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
26 Kim SY, Park SH, Hong N, Kim JH, Hong SM. Primary solid pancreatic tumors: recent imaging findings updates with pathology correlation. Abdom Imaging. 2013;38:1091-1105. [PMID: 23640523 DOI: 10.1007/s00261-013-0004-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Fagenson AM, Grossi SM, Musgrove K, Solomon N, de la Vega PR, Castro G, Pitt HA, Varella M, Zavallos J, Acuna J. Ethnic and racial disparities of pancreatic adenocarcinoma in Florida. HPB 2020;22:735-43. [DOI: 10.1016/j.hpb.2019.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Nolen BM, Brand RE, Prosser D, Velikokhatnaya L, Allen PJ, Zeh HJ, Grizzle WE, Huang Y, Lomakin A, Lokshin AE. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. PLoS One. 2014;9:e94928. [PMID: 24747429 DOI: 10.1371/journal.pone.0094928] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
29 DaVee T, Coronel E, Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Nogueras González GM, Bhutani MS, Ross WA, Weston BR, Lee JH. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Gastrointest Endosc 2018;87:1443-50. [PMID: 29309780 DOI: 10.1016/j.gie.2017.12.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
30 Chiaro MD, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: Is it really possible today? World J Gastroenterol 2014; 20(34): 12118-12131 [PMID: 25232247 DOI: 10.3748/wjg.v20.i34.12118] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 60] [Article Influence: 10.4] [Reference Citation Analysis]
31 Chen Q, Yuan H, Shi GD, Wu Y, Liu DF, Lin YT, Chen L, Ge WL, Jiang K, Miao Y. Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case-control studies. Onco Targets Ther 2018;11:2709-23. [PMID: 29785120 DOI: 10.2147/OTT.S157759] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
32 Long NP, Yoon SJ, Anh NH, Nghi TD, Lim DK, Hong YJ, Hong SS, Kwon SW. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer. Metabolomics 2018;14:109. [PMID: 30830397 DOI: 10.1007/s11306-018-1404-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
33 Jiang N, Dai Q, Su X, Fu J, Feng X, Peng J. Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. Mol Biol Rep 2020;47:4587-629. [PMID: 32333246 DOI: 10.1007/s11033-020-05435-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 67.0] [Reference Citation Analysis]
34 Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer. Cancer J 2014;20:203-6. [PMID: 24855008 DOI: 10.1097/PPO.0000000000000046] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
35 Frič P, Škrha J, Šedo A, Zima T, Bušek P, Kmochová K, Laclav M, Bunganič B, Solař S, Hrabal P, Bělina F, Záruba P, Škrha P, Zavoral M. Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers. European Journal of Gastroenterology & Hepatology 2016;28:e33-43. [DOI: 10.1097/meg.0000000000000727] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
36 Lee KH, Dominici F, Schrag D, Haneuse S. Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer. J Am Stat Assoc 2016;111:1075-95. [PMID: 28303074 DOI: 10.1080/01621459.2016.1164052] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]